About Positron
Positron is a publicly listed company based in Fishers (United States) founded in 1983. It operates as a PET and PET-CT medical imaging systems are provided for healthcare. It operates on a HealthTech model. Positron has completed 2 acquisitions, including IS2 Medical Systems and Manhattan Isotope Technology. Positron offers products and services including NeuSight PET-CT 64-Slice Scanner. Its focus areas include Medical Devices and Diagnostic Imaging. Its legal entity is POSITRON CORP. Its competitors include SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
Positron is engaged in the development and provision of advanced cardiac imaging solutions through PET and PET-CT technologies. The company operates in the healthcare sector, specializing in molecular imaging for cardiac diagnostics. Their flagship product, the NeuSight PET-CT 64-Slice Scanner, is designed to enhance precision, speed, and patient comfort. Positron is committed to supporting cardiologists with innovative tools and clinical support to improve patient outcomes and drive the adoption of cardiac PET imaging.
- Headquarters Fishers, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website positron.com
- Social LinkedIn
- Legal Name Positron Corp.
- Annual Revenue$461.45 K (USD)-21.45as on Dec 31, 2025
- Net Profit-$10.6 M (USD)-345.69as on Dec 31, 2025
- EBITDA-$10.44 M (USD)-381.99as on Dec 31, 2025
- Latest Funding Round$8M (USD), Post-IPO
Mar 2025
- Investments & AcquisitionsIS2 Medical Systems
& 1 more
Products & Services of Positron
Positron offers a comprehensive portfolio of products and services, including NeuSight PET-CT 64-Slice Scanner.
Advanced PET-CT scanner for precise cardiac imaging diagnostics.
Funding Insights of Positron
- Total Rounds 3
- Last Round Post-IPO — $8M
- First Round $1.5M
(Mar 2009)
All 3 funding rounds of Positron with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $8M | Post-IPO | – | – | – |
| Nov 2012 | $1.3M | Post-IPO | – | – | – |
| Mar 2009 | $1.5M | Post-IPO | – | – | – |
IPO & Listings of Positron
Positron is a publicly listed company on the OTC with ticker symbol POSC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jan 1999
- Listed onOTCMKTS: POSC
- Listed entityPositron Corp.
- Exchange sectorHealth technology
- ISINUS7373976049
- Share price$1.65 (-3.51% on the day) · 2026-10-13
- Market capitalisation$54.2M
- EPS (diluted, trailing year)$-0.31
- Volume (last session)9,267
Financials of Positron
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $461,450 | -$10.6M | -$10.4M |
| 2024 | $587,500 | -$2.4M | -$2.2M |
| 2023 | $734,670 | -$1.6M | -$1.3M |
| 2022 | $727,580 | -$2.9M | -$2.6M |
| 2021 | $881,950 | -$595,080 | -$736,920 |
Detailed financial statements for Positron
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Positron
Positron has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include IS2 Medical Systems and Manhattan Isotope Technology.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
PET isotope for mycardial perfusion imaging | manisotech.com | Los Alamos, United States | 2009 | Nov 2011 | •••• | |
Medical diagnostic nuclear imaging cameras are developed for clinical applications. | is2medical.com | Ottawa, Canada | 1994 | Jun 2006 | •••• |
Complete acquisition details for Positron
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Positron
6 dated milestones of Positron across 42 years, from founding to its latest funding, stage changes and deals.
- Founded Positron is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires IS2 Medical Systems.
- Funding First funding round of $1.5M.
- Acquisition Acquires Manhattan Isotope Technology.
- Funding Latest funding round, Post-IPO, of $8.0M.
Competitors of Positron
Positron has 10 listed competitors in our database, 7 of them funded. They include SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| realviewimaging.com | 2008 | Yokneam Illit, Israel | $25M | – | 3D holographic display solutions for medical imaging are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. |
Detailed competitors of Positron
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Positron
The website of Positron (positron.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 11% vs previous month
Websites whose visitors overlap most with Positron. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| opusgtx.com | 100% | 6.4K | #3,312,022 | View details | |
| celltexbank.com | 93% | 3.1K | #5,568,175 | View details |
Top companies in Imaging Diagnostics
10 companies that operate in the same segment as Positron (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Positron
Complete news archive for Positron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Positron
Positron was founded in 1983 and raised its 1st funding round 26 years after it was founded.
Positron is headquartered in Fishers, United States. It is registered at Fishers, Indiana, United States.
Annual revenue of Positron is $461.45K as on Dec 31, 2025.
Positron is engaged in the development and provision of advanced cardiac imaging solutions through PET and PET-CT technologies. The company operates in the healthcare sector, specializing in molecular imaging for cardiac diagnostics. Their flagship product, the NeuSight PET-CT 64-Slice Scanner, is designed to enhance precision, speed, and patient comfort. Positron is committed to supporting cardiologists with innovative tools and clinical support to improve patient outcomes and drive the adoption of cardiac PET imaging.
Positron's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Positron offers NeuSight PET-CT 64-Slice Scanner.
Yes, Positron is publicly traded on OTC under the ticker symbol POSC.
Positron has made 2 acquisitions, including IS2 Medical Systems, and Manhattan Isotope Technology.
Positron operates through Positron Corp.